To begin investigating a potential mechanism behind the smaller, less developed tumors in Sirt2−/− HCC mice, the amount of c-MYC in Sirt2−/− vs. Sirt2+/+ HCCs was measured. The gene discussed is SIRT2; the disease is hepatocellular carcinoma.